Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 62756-090

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 62756-090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-medroxy-carton (Spl Medroxy Carton)

This document pertains to a single-dose vial of medroxyprogesterone acetate injectable suspension, which is a contraceptive medication for intramuscular use only. The vial must be stored upright at a temperature range of 20°C to 25°C. The accompanying text describes the contents of the vial and dosage instructions, which indicate that the medication must be shaken vigorously before use. The manufacturer is Sun Pharmaceutical Industries, Inc., and the medication is distributed by the same company in the United States. The text also includes identifying numbers for the National Drug Code and product lot.*

FDA Label Image

Spl-medroxy-fig1 (Spl Medroxy Fig1)

FDA Label Image

Spl-medroxy-label (Spl Medroxy Label)

This is a description of a medication with the NDC code 62756-090-40 called Niccian’e SISPEISRD. It is manufactured by Sun Pharmaceutical Ind. Ltd in India and distributed by Sun Pharmacetical Ind. Inc. It is intended for intramuscular use only and has a concentration of 150mg/mL. The medication is stored upright at 20° to 25°C and is dispensed in 1mL single-dose vials. The full prescribing information should be reviewed before use. Shake well before use. Batch and Rx information can be found on the label.*

FDA Label Image

Spl-medroxy-pil (Spl Medroxy Pil)

This is a description of various methods of birth control and their effectiveness rates. The text describes the number of pregnancies per 100 women within different methods, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal rings. The text also mentions condoms, diaphragms, and avoiding sex during the most fertile days of the menstrual cycle as potential methods of birth control.*

FDA Label Image

Spl-medroxy-structure (Spl Medroxy Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.